Total Payments
$7,093
2024 Payments
$392.93
Companies
42
Transactions
401
Medicare Patients
9,439
Medicare Billing
$843,702
Payment Breakdown by Category
Food & Beverage$6,940 (97.8%)
Education$153.06 (2.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,940 | 395 | 97.8% |
| Education | $153.06 | 6 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $941.54 | 67 | $0 (2023) |
| Boston Scientific Corporation | $837.70 | 34 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $783.94 | 46 | $0 (2023) |
| Amgen Inc. | $634.45 | 45 | $0 (2024) |
| Medtronic Vascular, Inc. | $336.03 | 23 | $0 (2020) |
| Astellas Pharma US Inc | $335.63 | 14 | $0 (2020) |
| Philips North America LLC | $296.42 | 6 | $0 (2024) |
| Abbott Laboratories | $290.27 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $272.35 | 20 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $271.04 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $392.93 | 11 | Philips North America LLC ($296.42) |
| 2023 | $692.94 | 29 | Janssen Pharmaceuticals, Inc ($124.59) |
| 2022 | $353.51 | 23 | E.R. Squibb & Sons, L.L.C. ($58.79) |
| 2021 | $551.94 | 36 | BOSTON SCIENTIFIC CORPORATION ($141.87) |
| 2020 | $757.65 | 43 | Medtronic Vascular, Inc. ($217.63) |
| 2019 | $1,231 | 75 | Boston Scientific Corporation ($274.97) |
| 2018 | $1,298 | 89 | Janssen Pharmaceuticals, Inc ($291.73) |
| 2017 | $1,816 | 95 | E.R. Squibb & Sons, L.L.C. ($348.17) |
All Payment Transactions
401 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/15/2024 | Philips North America LLC | (CM9) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $66.64 | General |
| Category: Medical Device | ||||||
| 08/15/2024 | Philips North America LLC | (CM9) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $66.63 | General |
| Category: Medical Device | ||||||
| 07/15/2024 | Philips North America LLC | (CM9) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $43.70 | General |
| Category: Medical Device | ||||||
| 07/15/2024 | Philips North America LLC | (CM9) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $43.70 | General |
| Category: Medical Device | ||||||
| 05/09/2024 | Philips North America LLC | (5091) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $43.39 | General |
| Category: Medical Device | ||||||
| 04/02/2024 | Philips North America LLC | (5091) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $32.36 | General |
| Category: Medical Device | ||||||
| 03/13/2024 | BIOTRONIK INC. | AMVIA EDGE (Device), BIOMONITOR | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Cardiology | ||||||
| 01/17/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 01/05/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Cardiac Rhythm Management | ||||||
| 01/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/13/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/17/2023 | Medtronic, Inc. | AZURE XT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $33.08 | General |
| Category: Pacemakers | ||||||
| 09/26/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/11/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $16.60 | General |
| Category: Not Applicable | ||||||
| 08/28/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $17.22 | General |
| Category: Not Applicable | ||||||
| 08/25/2023 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 08/22/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/15/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 07/12/2023 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $18.10 | General |
| Category: Medical Device | ||||||
| 07/12/2023 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $18.10 | General |
| Category: Medical Device | ||||||
| 06/14/2023 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $18.57 | General |
| Category: Medical Device | ||||||
| 06/14/2023 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $18.57 | General |
| Category: Medical Device | ||||||
| 06/13/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $43.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/19/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $14.98 | General |
| Category: Not Applicable | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,970 | 3,212 | $595,193 | $188,958 |
| 2022 | 23 | 2,144 | 3,474 | $626,904 | $200,867 |
| 2021 | 23 | 2,387 | 3,699 | $583,492 | $214,219 |
| 2020 | 23 | 2,938 | 4,239 | $666,110 | $239,658 |
Total Patients
9,439
Total Services
14,624
Medicare Billing
$843,702
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 402 | 642 | $128,400 | $55,501 | 43.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 108 | 213 | $141,908 | $33,117 | 23.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 240 | 440 | $111,825 | $28,888 | 25.8% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 106 | 212 | $42,460 | $18,190 | 42.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 214 | 273 | $32,760 | $16,447 | 50.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 42 | 168 | $15,552 | $7,186 | 46.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 76 | 246 | $15,990 | $5,255 | 32.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 47 | 47 | $14,100 | $4,918 | 34.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 34 | $10,200 | $4,304 | 42.2% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 76 | 245 | $13,475 | $3,778 | 28.0% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 81 | 81 | $22,680 | $3,682 | 16.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 282 | 346 | $22,490 | $3,430 | 15.3% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 64 | 67 | $4,355 | $1,475 | 33.9% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 34 | 34 | $5,338 | $636.79 | 11.9% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 31 | 31 | $1,240 | $551.49 | 44.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 34 | 34 | $2,720 | $486.18 | 17.9% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 17 | 17 | $765.00 | $333.20 | 43.6% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 34 | 34 | $6,800 | $322.10 | 4.7% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 25 | 25 | $625.00 | $211.70 | 33.9% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 11 | 11 | $1,210 | $142.63 | 11.8% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 12 | 12 | $300.00 | $103.68 | 34.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 391 | 605 | $121,000 | $49,762 | 41.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 105 | 208 | $142,306 | $33,891 | 23.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 260 | 484 | $123,675 | $32,118 | 26.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 294 | 419 | $50,280 | $26,088 | 51.9% |
About Dr. Mark Coker, M.D
Dr. Mark Coker, M.D is a Cardiovascular Disease healthcare provider based in Ladson, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235189218.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Coker, M.D has received a total of $7,093 in payments from pharmaceutical and medical device companies, with $392.93 received in 2024. These payments were reported across 401 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($6,940).
As a Medicare-enrolled provider, Coker has provided services to 9,439 Medicare beneficiaries, totaling 14,624 services with total Medicare billing of $843,702. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology, Nuclear Imaging & Therapy
- Location Ladson, SC
- Active Since 05/11/2006
- Last Updated 04/25/2017
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1235189218
Products in Payments
- ELIQUIS (Drug) $1,067
- XARELTO (Drug) $783.94
- WATCHMAN (Device) $601.89
- Repatha (Biological) $342.25
- Corlanor (Drug) $292.20
- BRILINTA (Drug) $271.09
- (CM9) Amb Mon & Diag Und (Device) $220.67
- Cardiac Monitoring Suite (Device) $207.95
- Reveal LINQ (Device) $187.22
- ENTRESTO (Drug) $183.06
- LifeVest (Device) $171.47
- LEXISCAN (Drug) $157.63
- SYNERGY BIOABSORBABLE POLYMER DRUG-ELUTING STENT SYSTEM (Device) $123.70
- TURBOELITE (Device) $112.87
- VERQUVO (Drug) $97.96
- PRALUENT (Drug) $93.10
- AZURE XT DR MRI SURESCAN (Device) $89.38
- LEQVIO (Drug) $87.98
- Confirm Rx (Device) $84.98
- WATCHMAN Access System (Device) $81.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Ladson
Mr. Frederick Funke, Md, MD
Cardiovascular Disease — Payments: $19,511
Cardiovascular Disease $19,511
Dr. Jason Coker, M.d, M.D
Cardiovascular Disease — Payments: $17,792
Cardiovascular Disease $17,792
Christopher Mccarty, M.d, M.D
Cardiovascular Disease — Payments: $16,917
Cardiovascular Disease $16,917
Dr. Mark Mataosky, M.d, M.D
Cardiovascular Disease — Payments: $7,114
Cardiovascular Disease $7,114
Chris Kennedy, M.d, M.D
Cardiovascular Disease — Payments: $6,391
Cardiovascular Disease $6,391
Dr. Sofy Landes, Md, MD
Cardiovascular Disease — Payments: $5,151
Cardiovascular Disease $5,151